Home
Merck Clinical Trials

Merck Clinical Trials Market Share Analysis for July 2026

Taking part in a clinical trial can come with a lot of questions. Our common clinical trial questions may help you decide if joining a clinical trial is right for you.

Health > Biotechnology and Pharmaceuticals

Domainmerckclinicaltrials.com

Year Founded--

Employees> 10001

Annual Revenue--

Merck Clinical Trials

Merck Clinical Trials (including company regionals)

merckclinicaltrials.com

See more website traffic and engagement information

Total visits to Merck Clinical Trials's top domains

Understand Merck Clinical Trials market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

merckclinicaltrials.com225.4K

See more with Sales Intelligence

Avg. visit duration in Merck Clinical Trials's top domains

Analyze Merck Clinical Trials engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

merckclinicaltrials.com00:01:05

See more with Sales Intelligence

Avg. pageviews on Merck Clinical Trials's top domains

See how Merck Clinical Trials keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

merckclinicaltrials.com1.72

See more with Sales Intelligence

Merck Clinical Trials top competitors by domain

Top similar sites in July 2026, ranked by their affinity

clinicaltrials.govCompany NameClinicalTrials.govEmployees201 - 500HQUnited States, North Carolina, DurhamAnnual revenue$15M - $25MTotal visits3.2MHealth > Health - Other

Top technologies used by Merck Clinical Trials

These are the website technologies, by industry, used by Merck Clinical Trials top domains

Social (6)

Facebook Connect

Conversion & Analytics (4)

Google Analytics

Widget (4)

reCAPTCHA

Advertising (3)

DoubleClick

More Technologies

9

See all

News & Signals from Merck Clinical Trials

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMerck & Co. launches Enlicitide Decanoate.Merck has introduced 'Enlicitide Decanoate,' the first oral PCSK9 inhibitor for high cholesterol and heart disease.

NewsMerck & Co. launched beta version of M-TrustTM on Dec 1st '24.| In December 2024, Merck, a prominent scientific and technology corporation, unveiled a beta version of M-TrustTM, a secure cyber-physical trust platform designed to address the escalating problems of counterfeiting, product safety, and traceability.

NewsMerck & Co. launched Phase 3 Clinical Trials for Pembrolizumab and Enfortumab Vedotin on Aug 1st '23.In August 2023, Merck Sharp & Dohme LLC announced a study of Phase 3 Clinical Trials for Pembrolizumab and Enfortumab Vedotin.